Ignite Creation Date:
2025-12-24 @ 11:18 PM
Ignite Modification Date:
2026-01-12 @ 10:58 PM
Study NCT ID:
NCT04375956
Status:
UNKNOWN
Last Update Posted:
2021-12-20
First Post:
2020-04-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study on Pembrolizumab in Recurrent, Platinum Resistant, CPS >1 Positive Ovarian, Fallopian Tube and Primary Peritoneal Cancer Patients
Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organization: